Navigation Links
Synvista Therapeutics Appoints William Federici to its Board of Directors
Date:10/10/2008

MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announces that it has appointed William (Bill) Federici, 49, to its Board of Directors, expanding the board to five members.

Mr. Federici joined West Pharmaceutical Services as Vice President and Chief Financial Officer in August of 2003. Under his financial leadership, West Pharmaceutical's revenues have grown to more than $1.0 billion from $300 million. He has more than 20 years of public accounting experience, and was previously National Industry Director for Pharmaceuticals of KPMG LLP from June 2002 until August 2003. Prior to working at KPMG, he was an audit partner with Arthur Andersen, LLP where he began his career. During his tenure at Arthur Andersen, Mr. Federici worked with several major pharmaceutical companies and eventually became Global Pharmaceutical Industry Head from 1998 to 2002.

Noah Berkowitz, M.D., President and Chief Executive Officer of Synvista said, "We are fortunate that Bill has agreed to join our board, and we intend to tap into his significant knowledge base with respect to both his financial and pharmaceutical experience. We believe his background is a perfect fit for Synvista as we grow from a development stage company to one on the verge of launching a diagnostic product into the $79 billion diabetes market."

Mr. Federici is a past president and current Board member of CancerCare of New Jersey. He received a BA degree from Livingston College at Rutgers and an MBA from the Graduate School of Management at Rutgers.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing diagnostics and drugs to diagnose, treat and prevent cardiovascular disease in pe
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
2. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
4. Cell Therapeutics Regains Compliance with NASDAQs Minimum Bid Price Requirement
5. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
6. Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
7. Afid Therapeutics Inc.s New Anticoagulant Heparin Replacement Passes in Vivo Test
8. Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
9. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
10. TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
11. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... CT (PRWEB) , ... September 02, 2015 , ... ... $1 million gift from the Abraham and Mildred Goldstein Charitable Trust to establish ... timing of the gift comes six months after WCHN recruited nationally known gynecologic ...
(Date:9/2/2015)... ... September 02, 2015 , ... Date and time: Oct. 3, 2015, 9 ... School, 600 Tomlinson Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes ... New York Times best-selling author Sam Keen based on his new book which he ...
(Date:9/2/2015)... ... September 02, 2015 , ... ERT, a ... cloud analytics and workflow solutions today announced the September 2015 installments to ... participate in interactive programs in which ERT scientists and partner subject matter ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Affairs Officer following the departure of Kristen Dietz, former Chief Operations Officer. ... released the following statement welcoming Mr. Salot: “ Stanley H. Salot Jr , ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... a large stream of mixed documents that include EOBs, payments, and payment related ... extracting the data needed to reconcile their billing, with one efficient process and ...
Breaking Medicine News(10 mins):Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:Healtec® Announces Executive Leadership Change 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2
... defenses, making antibiotics more effective , , WEDNESDAY, March ... engineered a virus that disables the defense systems ... , The scientists said this approach could ... and kill bacteria that have already become antibiotic ...
... progressive degeneration of retinal ganglion cells and their axons ... to identify a way to stop or prevent the ... together a panel of 39 scientists to discuss the ... from the Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference ...
... Wash., March 4 Verathon(R) is pleased to ... instrument, with AortaScan(TM) Mode to help physicians identify ... This new addition to the BladderScan(R) BVI 9000 ... PriMed MidWest 2009 conference in Rosemont, IL on ...
... 4 The National Council on Disability (NCD) today ... health care provided to service members and veterans with ... (TBI).According to NCD Chairperson John R. Vaughn, "The wars ... are currently disabling for many, and potentially disabling for ...
... OAKLAND, Calif., March 4 Chronic kidney disease increases ... (AF), the most common type of heart arrhythmia, according ... the current online issue of Circulation. It has ... risk factor for cardiovascular disease. This study is the ...
... Any diet will do? Not if you want to lose fat ... levels so you,ll be less likely to develop diabetes and heart ... to cheat on your diet. And not if you want to ... have a better chance of achieving all these goals if you ...
Cached Medicine News:Health News:Engineered Viruses Could Battle Superbugs 2Health News:Experts examine causes, treatment and prevention of glaucoma 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 3Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 4Health News:National Council on Disability Says More Needs to be Done for Service Members and Veterans With Post Traumatic Stress Disorder and Traumatic Brain Injury 2Health News:National Council on Disability Says More Needs to be Done for Service Members and Veterans With Post Traumatic Stress Disorder and Traumatic Brain Injury 3Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 2Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 3Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 4Health News:Is one diet as good as another? U of I study says no and tells you why 2Health News:Is one diet as good as another? U of I study says no and tells you why 3
(Date:9/2/2015)... , Sept. 2, 2015 About Chronic ... a malignant condition characterized by increased production of lymphocytes. ... B-lymphocytes and then it can spread to other parts ... later stages because of the slow buildup of the ... malignancy spreads to the spleen, liver, and lymph nodes. ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... the "Inhaled Drug Delivery (London, UK - November ... This Inhaled Drug Delivery meeting will cover industry case ... much more. The Co-Chairmen are Dr Steven Nichols ... Senior Director, Mylan. Companies participating include: ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
Breaking Medicine Technology:Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
... Corporation (NASDAQ: HSKA ), a provider of ... today announced that Robert Grieve, Heska,s Chairman and CEO, will ... Conference at 3:20 p.m. ET on Monday, January 9, 2012 ... York Hotel.  Heska management will be available during the day ...
... BROOKLYN, N.Y., Dec. 21, 2011 Senate Democratic Leader ... the President and CEO of Walgreens Inc., expressing his ... made prescription drug coverage more affordable for many of ... business.  Walgreens has administered the program through ...
Cached Medicine Technology:Heska to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference 2
... 525 is an assayed quality control ... of blood gas, electrolyte, metabolite, and ... this control makes it the ideal ... It is available in three (3) ...
Xsera Rapid HIV-1/2 Antibody Controls are unassayed positive and negative quality control materials used for monitoring the performance of qualitative rapid HIV-1 and HIV-2 test kits....
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
For the qualitative detection of human occult blood in fecal specimens....
Medicine Products: